The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Immune Evasion Strategies of Glioblastoma
Open accessAbstract
Glioblastoma (GBM) is the most devastating brain tumor, with associated poor prognosis. Despite advances in surgery and chemoradiation, the survival of afflicted patients has not improved significantly in the past three decades. Immunotherapy has been heralded as a promising approach in treatment of various cancers; however, the immune privileged environment of the brain usually curbs the optimal expected response in central nervous system malignancies. In addition, GBM cells create an immunosuppressive microenvironment and employ various methods to escape immune surveillance. The purpose of this review is to highlight the strategies by which GBM cells evade the host immune system. Further understanding of these strategies and the biology of this tumor will pave the way for developing novel immunotherapeutic approaches for treatment of GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Self-citationImmune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308573 · Cited by 2,834
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Chinot, O. L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A. F., Hoang-Xuan, K., Kavan, P., Cernea, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1308345 · Cited by 2,557
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463 · cited 2×
“Inhibiting the CSF-1 receptor can shift the polarization of TAMs away from M2, hinder their tumor-promoting functions, and increase survival of the GBM-bearing mice (50).”
BackgroundFcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2007) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,344
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074
Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., Durham, N., Meyer, C., Harris, T. J., Albesiano, E., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.025 · Cited by 889
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Glioblastoma survival in the United States before and during the temozolomide era
Johnson, D. R., & O’Neill, B. P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0749-4 · Cited by 720
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686
Revisiting the Mechanisms of CNS Immune Privilege
Louveau, A., Harris, T. H., & Kipnis, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.006 · Cited by 682
Tseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 657
Ford, A. L., Goodsall, A. L., Hickey, W. F., & Sedgwick, J. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4309 · Cited by 631
Carrasco, Y. R., & Batista, F. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.007 · Cited by 617
PD-L1 expression and prognostic impact in glioblastoma
Nduom, E. K., Wei, J., Yaghi, N. K., Huang, N., Kong, L.-Y., Gabrusiewicz, K., Ling, X., Zhou, S., Ivan, C., Chen, J. Q., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov172 · Cited by 596
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1
Hussain, S. F., Yang, D., Suki, D., Aldape, K., Grimm, E., & Heimberger, A. B. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-008 · Cited by 592
What is the blood–brain barrier (not)?
Bechmann, I., Galea, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.007 · Cited by 520 · cited 1×
“APCs are present in many areas of the brain, including leptomeninges, ventricles, and perivascular spaces (69, 70).”
BackgroundBloch, O., Crane, C. A., Kaur, R., Safaee, M., Rutkowski, M. J., & Parsa, A. T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3314 · Cited by 458
Ohtsuki, S., & Terasaki, T. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9374-5 · Cited by 454
Prins, R. M., Soto, H., Konkankit, V., Odesa, S. K., Eskin, A., Yong, W. H., Nelson, S. F., & Liau, L. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2563 · Cited by 451
Cserr, H. F., Harling‐Berg, C. J., & Knopf, P. M. (1992) · Brain Pathology · doi:10.1111/j.1750-3639.1992.tb00703.x · Cited by 451
Coniglio, S. J., Eugenin, E., Dobrenis, K., Stanley, E. R., West, B. L., Symons, M. H., & Segall, J. E. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00217 · Cited by 428
Strle, K., Zhou, J.-H., Shen, W.-H., Broussard, S. R., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2001) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v21.i5.20 · Cited by 400
Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion
Markovic, D. S., Vinnakota, K., Chirasani, S., Synowitz, M., Raguet, H., Stock, K., Sliwa, M., Lehmann, S., Kälin, R., van Rooijen, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804273106 · Cited by 391
Mitchell, D. A., Xie, W., Schmittling, R., Learn, C., Friedman, A., McLendon, R. E., & Sampson, J. H. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-035 · Cited by 388
Graeber, M. B., Scheithauer, B. W., & Kreutzberg, G. W. (2002) · Glia · doi:10.1002/glia.10147 · Cited by 387
The Molecular Constituents of the Blood–Brain Barrier
Chow, B. W., & Gu, C. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.003 · Cited by 380
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Kahlon, K. S., Brown, C., Cooper, L. J. N., Raubitschek, A., Forman, S. J., & Jensen, M. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0454 · Cited by 368
Role of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 353
Perivascular Spaces and the Two Steps to Neuroinflammation
Owens, T., Bechmann, I., & Engelhardt, B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818f9ca8 · Cited by 353
Fecci, P. E., Ochiai, H., Mitchell, D. A., Grossi, P. M., Sweeney, A. E., Archer, G. E., Cummings, T., Allison, J. P., Bigner, D. D., & Sampson, J. H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2070 · Cited by 347
Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
Heimberger, A. B., Abou-Ghazal, M., Reina-Ortiz, C., Yang, D. S., Sun, W., Qiao, W., Hiraoka, N., & Fuller, G. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0320 · Cited by 332
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10
Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. T., & Schall, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1285-1292.2002 · Cited by 322
Suppression of antigen presentation by IL-10
Mittal, S. K., & Roche, P. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.009 · Cited by 314
Antagonists of PD-1 and PD-L1 in Cancer Treatment
Lipson, E. J., Forde, P. M., Hammers, H.-J., Emens, L. A., Taube, J. M., & Topalian, S. L. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.013 · Cited by 306
Flow Cytometric Characterization of Tumor-associated Macrophages in Experimental Gliomas
Badie, B., & Schartner, J. M. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00035 · Cited by 278
Wesolowska, A., Kwiatkowska, A., Slomnicki, L., Dembinski, M., Master, A., Sliwa, M., Franciszkiewicz, K., Chouaib, S., & Kaminska, B. (2008) · Oncogene · doi:10.1038/sj.onc.1210683 · Cited by 258
Detection of human cytomegalovirus in different histological types of gliomas
Scheurer, M. E., Bondy, M. L., Aldape, K. D., Albrecht, T., & El-Zein, R. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0359-1 · Cited by 244
Belcaid, Z., Phallen, J. A., Zeng, J., See, A. P., Mathios, D., Gottschalk, C., Nicholas, S., Kellett, M., Ruzevick, J., Jackson, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101764 · Cited by 244
Rodrigues, J. C., Gonzalez, G. C., Zhang, L., Ibrahim, G., Kelly, J. J., Gustafson, M. P., Lin, Y., Dietz, A. B., Forsyth, P. A., Yong, V. W., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop023 · Cited by 244
Jordan, J. T., Sun, W., Hussain, S. F., DeAngulo, G., Prabhu, S. S., & Heimberger, A. B. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0336-x · Cited by 243
Gustafson, M. P., Lin, Y., New, K. C., Bulur, P. A., O'Neill, B. P., Gastineau, D. A., & Dietz, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq001 · Cited by 239
Antigen presentation by monocytes and monocyte-derived cells
Randolph, G. J., Jakubzick, C., & Qu, C. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.010 · Cited by 237
Calzascia, T., Masson, F., Di Berardino-Besson, W., Contassot, E., Wilmotte, R., Aurrand-Lions, M., Rüegg, C., Dietrich, P.-Y., & Walker, P. R. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.008 · Cited by 235
Kjellman, C., Olofsson, S. P., Hansson, O., Von Schantz, T., Lindvall, M., Nilsson, I., Salford, L. G., Sjögren, H.-O., & Widegren, B. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000520)89:3<251::aid-ijc7>3.0.co;2-5 · Cited by 224
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Wei, J., Wu, A., Kong, L.-Y., Wang, Y., Fuller, G., Fokt, I., Melillo, G., Priebe, W., & Heimberger, A. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016195 · Cited by 220
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Jacobs, J. F. M., Idema, A. J., Bol, K. F., Grotenhuis, J. A., de Vries, I. J. M., Wesseling, P., & Adema, G. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.020 · Cited by 211
Zhang, J., Sarkar, S., Cua, R., Zhou, Y., Hader, W., & Yong, V. W. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr289 · Cited by 196
(2002) · PubMed · Cited by 193
Pathologic patterns of interleukin 10 expression – A review
Trifunović, J., Miller, L., Debeljak, Ž., & Horvat, V. (2015) · Biochemia Medica · doi:10.11613/bm.2015.004 · Cited by 190
The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodova, S., Russell, S. E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S. P., MacGregor, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5664 · Cited by 183
Immune privilege or privileged immunity?
Forrester, J. V., Xu, H., Lambe, T., & Cornall, R. J. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.27 · Cited by 182
Parney, I., Petruk, K., Hao, C., Roa, W., Turner, J., & Ramsay, D. (2002) · Acta Neuropathologica · doi:10.1007/s004010100448 · Cited by 181
Chang, W. L. W., Baumgarth, N., Yu, D., & Barry, P. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8720-8731.2004 · Cited by 180
Huettner, C. S., Czub, S., Kerkau, S., Roggendorf, W., & Tonn, J. (1997) · PubMed · Cited by 180
Carvalho da Fonseca, A. C., & Badie, B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/264124 · Cited by 174
Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.
Huettner, C. S., Paulus, W., & Roggendorf, W. (1995) · Europe PMC (PubMed Central) · Cited by 173
Brain dendritic cells: biology and pathology
D’Agostino, P. M., Gottfried-Blackmore, A., Anandasabapathy, N., & Bulloch, K. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1018-0 · Cited by 173
Crane, C. A., Ahn, B. J., Han, S. J., & Parsa, A. T. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos014 · Cited by 169
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
Laman, J. D., & Weller, R. O. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9470-8 · Cited by 166
CNS macrophages and peripheral myeloid cells in brain tumours
Glaß, R., & Synowitz, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1274-2 · Cited by 160
Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., Ifergan, I., Chen, L., Bischof, F., Bar-Or, A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4794-04.2005 · Cited by 160
Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
Jackson, C. M., Ruzevick, J., Phallen, J. A., Belcaid, Z., & Lim, M. K. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/732413 · Cited by 158
Desbaillets, I., Tada, M., de Tribolet, N., Diserens, A., Hamou, M., & Meir, E. G. V. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580216 · Cited by 156
Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F. M., Heil, M., Tchaikovski, V., Waltenberger, J. L., Shibuya, M., Plate, K. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6241 · Cited by 156
CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)
Held‐Feindt, J., Hattermann, K., Müerköster, S. S., Wedderkopp, H., Knerlich‐Lukoschus, F., Ungefroren, H., Mehdorn, H. M., & Mentlein, R. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.018 · Cited by 154
Dziurzynski, K., Wei, J., Qiao, W., Hatiboğlu, M. A., Kong, L.-Y., Wu, A., Wang, Y., Cahill, D. P., Levine, N. B., Prabhu, S. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0414 · Cited by 150
Astrocytic Regulation of Human Monocytic/Microglial Activation
Kostianovsky, A. M., Maier, L. M., Anderson, R. C. E., Bruce, J. N., & Anderson, D. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5425 · Cited by 149
Glioblastomas Induce T-Lymphocyte Death by Two Distinct Pathways Involving Gangliosides and CD70
Chahlavi, A., Rayman, P., Richmond, A. L., Biswas, K., Zhang, R., Vogelbaum, M., Tannenbaum, C., Barnett, G., & Finke, J. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4395 · Cited by 141
Impaired capacity for upregulation of MHC class II in tumor‐associated microglia
Schartner, J. M., Hagar, A. R., Handel, M. M. V., Zhang, L., Nadkarni, N. V., & Badie, B. (2005) · Glia · doi:10.1002/glia.20201 · Cited by 134
Morimura, T., Neuchrist, C., Kitz, K., Budka, H., Scheiner, O., Kraft, D., & Lassmann, H. (1990) · Acta Neuropathologica · doi:10.1007/bf00294647 · Cited by 128
Gorbachev, A. V., Kobayashi, H., Kudo, D., Tannenbaum, C. S., Finke, J. H., Shu, S., Farber, J. M., & Fairchild, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2278 · Cited by 126
Prins, R. M., Wang, X., Soto, H., Young, E., Lisiero, D. N., Fong, B., Everson, R. G., Yong, W. H., Lai, A., Li, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ae4 · Cited by 120
Self-citationCandolfi, M., Curtin, J. F., Yagiz, K., Assi, H. H., Wibowo, M., Alzadeh, G. E., Foulad, D. S., Muhammad, A. G., Salehi, S., Keech, N., et al. (2011) · Neoplasia · doi:10.1593/neo.11024 · Cited by 120
Expression of Fas ligand by microglia: possible role in glioma immune evasion
Badie, B., Schartner, J. M., Prabakaran, S., Paul, J. S., & Vorpahl, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00361-7 · Cited by 119
B7-homolog 1 expression by human glioma: a new mechanism of immune evasion
Wilmotte, R., Burkhardt, K., Kindler, V., Belkouch, M., Dussex, G. R., de Tribolet, N., Walker, P. R., & Dietrich, P. (2005) · Neuroreport · doi:10.1097/00001756-200507130-00010 · Cited by 116
Immune cell trafficking from the brain maintains CNS immune tolerance.
Mohammad, M., Tsai, V., Ruitenberg, M., Hassanpour, M., Li, H., Hart, P., Breit, S., Sawchenko, P., & Brown, D. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71544 · Cited by 116
Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
Waziri, A. E. (2009) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2009.08.005 · Cited by 110
Badie, B., Schartner, J. M., Klaver, J., & Vorpahl, J. (1999) · Neurosurgery · doi:10.1097/00006123-199905000-00075 · Cited by 109
Induced regulatory T cells in inhibitory microenvironments created by cancer
Whiteside, T. L. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927432 · Cited by 105
Cytokines and tumors of the central nervous system
Meir, E. G. V. (1995) · Glia · doi:10.1002/glia.440150308 · Cited by 97
Neonatal and adult microglia cross‐present exogenous antigens
Beauvillain, C., Donnou, S., Jarry, U., Scotet, M., Gascan, H., Delneste, Y., Guermonprez, P., Jeannin, P., & Couez, D. (2007) · Glia · doi:10.1002/glia.20565 · Cited by 89
Sakai, K., Shimodaira, S., Maejima, S., Udagawa, N., Sano, K., Higuchi, Y., Koya, T., Ochiai, T., Koide, M., Uehara, S., et al. (2015) · Journal of neurosurgery · doi:10.3171/2015.1.jns141554 · Cited by 88
Current Vaccine Trials in Glioblastoma: A Review
Xu, L. W., Chow, K. K. H., Lim, M. K., & Li, G. (2014) · Journal of Immunology Research · doi:10.1155/2014/796856 · Cited by 87
Self-citationB Lymphocytes Participate in Cross-Presentation of Antigen following Gene Gun Vaccination
Hon, H., Oran, A. E., Brocker, T., & Jacob, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5233 · Cited by 85
S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway
Zhang, L., Liu, W., Alizadeh, D., Zhao, D., Farrukh, O., Lin, J., Badie, S., & Badie, B. (2010) · Glia · doi:10.1002/glia.21118 · Cited by 83
Mieczkowski, J., Kocyk, M., Nauman, P., Gabrusiewicz, K. R., Sielska, M., Przanowski, P., Maleszewska, M., Rajan, W. D., Pszczolkowska, D., Tykocki, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5310 · Cited by 80
Whiteside, T. L., Mandapathil, M., & Schuler, P. J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798184334 · Cited by 79
Lasky, J. L., Panosyan, E. H., Plant, A., Davidson, T. B., Yong, W. H., Prins, R. M., Liau, L. M., & Moore, T. B. (2013) · PubMed · Cited by 76
Tumor Antigen Cross‐Presentation and the Dendritic Cell: Where it All Begins?
McDonnell, A. M., Robinson, B. W. S., & Currie, A. J. (2010) · Journal of Immunology Research · doi:10.1155/2010/539519 · Cited by 76
Microglia only weakly present glioma antigen to cytotoxic T cells
Flügel, A., Labeur, M. S., Grasbon‐Frodl, E., Kreutzberg, G. W., & Graeber, M. B. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00020-9 · Cited by 73
Recent developments on immunotherapy for brain cancer
Wainwright, D. A., Nigam, P., Thaçi, B., Dey, M., & Lesniak, M. S. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.679929 · Cited by 71
Badie, B., Bartley, B., & Schartner, J. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00350-8 · Cited by 70
Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cells
Tritschler, I., Gramatzki, D., Capper, D., Mittelbronn, M. G. A., Meyermann, R., Saharinen, J., Wick, W., Keski‐Oja, J., & Weller, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24443 · Cited by 63
Immunotherapeutic Advancements for Glioblastoma
Ampie, L., Woolf, E. C., & Dardis, C. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00012 · Cited by 60
Malignant glioma modulation of immune function: relative contribution of different soluble factors
Couldwell, W. T., Dore‐Duffy, P., Apuzzo, M. L. J., & Antel, J. P. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90052-9 · Cited by 56
Efficiently stimulated adult microglia cross‐prime naive CD 8+ T cells injected in the brain
Jarry, U., Jeannin, P., Pineau, L., Donnou, S., Delneste, Y., & Couez, D. (2013) · European Journal of Immunology · doi:10.1002/eji.201243040 · Cited by 50
T-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy
Walker, D., Chuah, T., Rist, M., & Pender, M. P. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.006 · Cited by 48
Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Sheng, K., Wright, M. D., & Apostolopoulos, V. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711798347207 · Cited by 43
Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy
Kirkbride, K. C., & Blobe, G. C. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.251 · Cited by 42
Su, Y., Jackson, E. K., & Gorelik, E. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0924-z · Cited by 39
Wei, B., Wang, L., Zhao, X., Du, C., Guo, Y., & Sun, Z. (2013) · Tumor Biology · doi:10.1007/s13277-013-1376-9 · Cited by 37
Expression of TGF‐β2 in Human Glioblastoma: A Role in Resistance to Immune Rejection?
Fontana, A., Bodmer, S., Frei, K., Malipiero, U., & Siepl, C. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514061.ch15 · Cited by 36
Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT
Camara-Quintana, J. Q., Nitta, R. T., & Li, G. (2012) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2012.01.011 · Cited by 28
Self-citationTang, X., Li, Q., Zhu, Y., Zheng, D., Dai, J., Ni, W., Wei, J., Xue, Y., Chen, K., Hou, W., et al. (2015) · PubMed · Cited by 22
Cervical lymph nodes play the role of regional lymph nodes in brain tumour immunity in rats
Okamoto, Yamashita, Hasegawa, Fujisawa, Yamashima, Hashimoto, Nonomura, Matsumoto, & Kida (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00165.x · Cited by 19
Lin, H., Song, T., & Hu, M. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp218 · Cited by 17
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Challenges to curing primary brain tumours
Aldape, K., Brindle, K. M., Chesler, L., Chopra, R., Gajjar, A., Gilbert, M. R., Gottardo, N., Gutmann, D. H., Hargrave, D., Holland, E. C., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0177-5 · Cited by 959
Epidemiology of Glioblastoma Multiforme–Literature Review
Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 630
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
Cossarizza, A., Chang, H., Radbruch, A., Akdis, M., Andrä, I., Annunziato, F., Bacher, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 542
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Metadata
- Authors
- Razavi, S.-M., Lee, K. E., Jin, B. E., Aujla, P. S., Gholamin, S., & Li, G.
- Venue
- Frontiers in Surgery
- Publisher
- Frontiers Media SA
- Published
- 2016-03-02
- Volume
- 3
- Pages
- 11-11
- ISSN
- 2296-875X (ISSN-L)
- OpenAlex
- W2325549616
- Cited by
- 262
- References
- 124
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.